Latest Pneumococcal conjugate vaccine Stories
James E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis ROCKVILLE, Md., July 1 /PRNewswire-USNewswire/ -- The Aeras Global TB Vaccine Foundation today announced that James E. Connolly has been named President and Chief Executive Officer.
PHILADELPHIA, May 14 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined that U.S. healthcare practitioners can resume the use of RotarixÂ® (Rotavirus Vaccine, Live, Oral), effective immediately.
New study reinforces urgent need for life-saving vaccines in Africa.
BEIJING, April 6 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Two of the largest pharmaceutical companies in the world have agreed to a 10-year commitment to supply new pneumonia vaccines to developing nations across the globe.
LONDON, March 23 /PRNewswire-FirstCall/ -- GSK (NYSE: GSK) has become one of the first manufacturers to sign a unique agreement with the GAVI Alliance (GAVI) that has the potential to save millions of children from dying in the world's poorest countries.
LONDON, March 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today confirmed that it has notified regulatory authorities of the presence of material from a virus called PCV-1 in its oral rotavirus vaccine, Rotarix(TM).
The Global Alliance on Vaccines and Immunization (GAVI) said on Monday that a further 4 billion dollars is needed if the global vaccines alliance is to meet its goal of supplying life-saving immunizations to millions of children in poor countries by 2015.
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.
Successor to Prevnar is intended for infants, young children SILVER SPRING, Md., Feb. 24 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.